rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2006-4-28
|
pubmed:abstractText |
In order to characterize the alteration of apoptotic regulatory molecule expression during tumor progression of renal cell carcinoma (RCC), we compared the expression between tumor and normal tissues, and evaluated the relationship of the expression in tumors with pathological and clinical characteristics.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0919-8172
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
257-64
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16643620-Adult,
pubmed-meshheading:16643620-Aged,
pubmed-meshheading:16643620-Aged, 80 and over,
pubmed-meshheading:16643620-Antigens, CD95,
pubmed-meshheading:16643620-Carcinoma, Renal Cell,
pubmed-meshheading:16643620-Disease Progression,
pubmed-meshheading:16643620-Female,
pubmed-meshheading:16643620-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:16643620-Humans,
pubmed-meshheading:16643620-Immunohistochemistry,
pubmed-meshheading:16643620-Kidney Neoplasms,
pubmed-meshheading:16643620-Male,
pubmed-meshheading:16643620-Middle Aged,
pubmed-meshheading:16643620-Neoplasm Staging,
pubmed-meshheading:16643620-Prognosis,
pubmed-meshheading:16643620-RNA, Neoplasm,
pubmed-meshheading:16643620-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:16643620-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16643620-Tumor Markers, Biological
|
pubmed:year |
2006
|
pubmed:articleTitle |
Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
|
pubmed:affiliation |
Division of Urology, Department of Surgery, Tottori University Faculty of Medicine, Yonago, Japan. seji3452@grape.med.tottori-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Comparative Study,
In Vitro
|